The Shaanxi medical device quality announcement (2022 issue 2, general issue 7, 2022 No. 9) released on the website of Shaanxi Provincial Drug Administration shows that in order to strengthen the quality supervision of medical devices and ensure the safety of public use of devices, Shaanxi provincial drug administration organizes the supervision and sampling inspection of medical devices in the production, trading enterprises and users of medical devices in the province. After inspection by Shaanxi medical device quality inspection institute, 28 batches of products that do not meet the standards are hereby announced.
\u3000\u3000
This sampling inspection found that the medical protective mask produced by Hunan Kangwo medical supplies Co., Ltd. and sold by Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy chain (Shaanxi) Co., Ltd. was unqualified, with the specification and model of 15cm × 11cm folding ear hanging type (non sterile type), production date or batch number 20211109 / 20211109
\u3000\u3000
For the unqualified medical devices found in the supervision and sampling inspection, Shaanxi Provincial Drug Administration has asked the relevant local and municipal drug regulatory departments to dispose of the production, operation and use units of unqualified medical devices according to law.
According to the annual report of Lbx Pharmacy Chain Joint Stock Company(603883) ( Lbx Pharmacy Chain Joint Stock Company(603883) . SH), Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy chain (Shaanxi) Co., Ltd. is referred to as “Shaanxi Lbx Pharmacy Chain Joint Stock Company(603883) / Shaanxi company”, which is a wholly-owned subsidiary of Lbx Pharmacy Chain Joint Stock Company(603883) .
